Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) Shares Outstanding (Diluted Average) (2020 - 2024)

Historic Shares Outstanding (Diluted Average) for Puma Biotechnology (PBYI) over the last 5 years, with Q4 2024 value amounting to $49.1 million.

  • Puma Biotechnology's Shares Outstanding (Diluted Average) rose 325.88% to $49.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $49.1 million, marking a year-over-year increase of 325.88%. This contributed to the annual value of $49.1 million for FY2024, which is 325.88% up from last year.
  • Latest data reveals that Puma Biotechnology reported Shares Outstanding (Diluted Average) of $49.1 million as of Q4 2024, which was up 325.88% from $47.6 million recorded in Q4 2023.
  • In the past 5 years, Puma Biotechnology's Shares Outstanding (Diluted Average) registered a high of $49.1 million during Q4 2024, and its lowest value of $39.6 million during Q4 2020.
  • For the 5-year period, Puma Biotechnology's Shares Outstanding (Diluted Average) averaged around $44.4 million, with its median value being $44.9 million (2022).
  • Per our database at Business Quant, Puma Biotechnology's Shares Outstanding (Diluted Average) surged by 268.53% in 2021 and then soared by 1055.92% in 2022.
  • Puma Biotechnology's Shares Outstanding (Diluted Average) (Quarter) stood at $39.6 million in 2020, then increased by 2.69% to $40.6 million in 2021, then rose by 10.56% to $44.9 million in 2022, then grew by 5.83% to $47.6 million in 2023, then grew by 3.26% to $49.1 million in 2024.
  • Its Shares Outstanding (Diluted Average) stands at $49.1 million for Q4 2024, versus $47.6 million for Q4 2023 and $44.9 million for Q4 2022.